摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-aminocarbonylamino-4-fluoro-6-(furan-3-yl)-7-methoxyindole-3-carboxamide | 1204578-77-7

中文名称
——
中文别名
——
英文名称
2-aminocarbonylamino-4-fluoro-6-(furan-3-yl)-7-methoxyindole-3-carboxamide
英文别名
2-(carbamoylamino)-4-fluoro-6-(furan-3-yl)-7-methoxy-1H-indole-3-carboxamide
2-aminocarbonylamino-4-fluoro-6-(furan-3-yl)-7-methoxyindole-3-carboxamide化学式
CAS
1204578-77-7
化学式
C15H13FN4O4
mdl
——
分子量
332.291
InChiKey
ZITVEQJIXHEWDR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    136
  • 氢给体数:
    4
  • 氢受体数:
    5

文献信息

  • NOVEL INDOLE DERIVATIVE HAVING, CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP
    申请人:Kawashima Kenji
    公开号:US20110124668A1
    公开(公告)日:2011-05-26
    The present invention relates to synthetic studies on novel indole derivatives having a carbamoyl group, a ureido group and a substituted oxy group or a salt thereof, and pharmaceutical actions of the derivatives. The compound and a salt thereof represented by the general formula (1) has an IKKβ inhibitory activity and is useful as a preventive and/or therapeutic agent for diseases considered to be associated with IKKβ. In the formula, R 1 represents a hydrogen atom, a lower alkyl group which may have a substituent, a hydroxy group, or a lower alkoxy group which may have a substituent, or the like; R 2 represents a hydrogen atom, a lower alkyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heterocyclic group which may have a substituent, or the like; R 3 represents a halogen atom, a lower alkyl group which may have a substituent, a lower alkenyl group which may have a substituent, a lower alkynyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, or the like; m represents 0, 1, 2, or the like.
    本发明涉及具有基甲酰基、尿素基和取代氧基或其盐的新型吲哚生物的合成研究以及其药理作用。通式(1)表示的化合物及其盐具有IKKβ抑制活性,并可用作预防和/或治疗与IKKβ相关的疾病的药物。在该式中,R1表示氢原子、可能具有取代基的较低烷基、羟基或可能具有取代基的较低烷氧基等;R2表示氢原子、可能具有取代基的较低烷基、可能具有取代基的较低环烷基、可能具有取代基的芳基或可能具有取代基的杂环基等;R3表示卤素原子、可能具有取代基的较低烷基、可能具有取代基的较低烯基、可能具有取代基的较低炔基、可能具有取代基的较低环烷基、可能具有取代基的芳基、可能具有取代基的杂环基等;m表示0、1、2或类似物。
  • NOVEL INDOLE DERIVATIVE HAVING CARBAMOYL GROUP, UREIDE GROUP AND SUBSTITUTED OXY GROUP
    申请人:Santen Pharmaceutical Co., Ltd
    公开号:EP2314575A1
    公开(公告)日:2011-04-27
    The present invention relates to synthetic studies on novel indole derivatives having a carbamoyl group, a ureido group and a substituted oxy group or a salt thereof, and pharmaceutical actions of the derivatives. The compound and a salt thereof represented by the general formula (1) has an IRKβ inhibitory activity and is useful as a preventive and/or therapeutic agent for diseases considered to be associated with IKKβ. In the formula, R1 represents a hydrogen atom, a lower alkyl group which may have a substituent, a hydroxy group, or a lower alkoxy group which may have a substituent, or the like; R2 represents a hydrogen atom, a lower alkyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, or a heterocyclic group which may have a substituent, or the like; R3 represents a halogen atom, a lower alkyl group which may have a substituent, a lower alkenyl group which may have a substituent, a lower alkynyl group which may have a substituent, a lower cycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heterocyclic group which may have a substituent, or the like; m represents 0, 1, 2, or the like.
    本发明涉及具有基甲酰基、基和取代氧基的新型吲哚生物或其盐的合成研究,以及这些衍生物的药物作用。通式(1)代表的化合物及其盐具有 IRKβ 抑制活性,可作为预防和/或治疗被认为与 IKKβ 有关的疾病的药物。式中,R1 代表氢原子、可能具有取代基的低级烷基、羟基或可能具有取代基的低级烷氧基等;R2 代表氢原子、可能具有取代基的低级烷基、可能具有取代基的低级环烷基、可能具有取代基的芳基或可能具有取代基的杂环基等;R3 代表卤素原子、可具有取代基的低级烷基、可具有取代基的低级烯基、可具有取代基的低级炔基、可具有取代基的低级环烷基、可具有取代基的芳基、可具有取代基的杂环基等;m 代表 0、1、2 或类似物。
  • NOVEL INDOLE DERIVATIVE HAVING CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP
    申请人:Santen Pharmaceutical Co., Ltd
    公开号:EP2314575B1
    公开(公告)日:2013-06-19
  • US8445529B2
    申请人:——
    公开号:US8445529B2
    公开(公告)日:2013-05-21
查看更多